Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kristen Thomas

Orthopaedic Surgery Portland, OR Medical Doctor

NPI 1235353996 CMS profile 1224096

501 N Graham St, Suite 200, Portland, OR 97227

Open in the dashboard

General payments

$19,250

63 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristen Thomas of Portland, OR is reported in the CMS Open Payments database as having received $19,250 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,656 17
2024 General $41 2
2023 General $58 2
2022 General $3,818 5
2021 General $4,350 6
2019 General $7,328 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristen Thomas
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Kristen Thomas were reported at $3,656. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Kristen Thomas Orthopaedic Surgery median Middle half National median
2019 $7,328 $644 $140–$2,844 $163
2020 $0 $312 $75–$1,860 $114
2021 $4,350 $520 $117–$2,495 $132
2022 $3,818 $598 $128–$2,731 $149
2023 $58 $461 $128–$2,264 $160
2024 $41 $497 $134–$2,475 $164
2025 $3,656 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Steelhead Surgical Inc $10,427 17 payments
  2. Arthrex, Inc. $4,144 23 payments
  3. Shoulder Innovations, Inc. $2,318 7 payments
  4. Zimmer Biomet Holdings, Inc. $911 5 payments
  5. Acumed LLC $768 2 payments
  6. Left Coast Surgical Inc $466 2 payments
  7. Stryker Corporation $85 2 payments
  8. Smith+Nephew, Inc. $63 1 payment
  9. Pacira Pharmaceuticals Incorporated $38 2 payments
  10. Novartis Pharmaceuticals Corporation $15 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $11,168 13 payments
  2. Travel and Lodging $6,358 16 payments
  3. Food and Beverage $1,700 33 payments
  4. Gift $24 1 payment
Products named General payments · program years 2019–2025
  1. InSet System $2,318 7 payments
  2. Acu-Loc Wrist Plating System $768 2 payments
  3. Elbow Plating System $768 2 payments
  4. Polarus 3 Solution $768 2 payments
  5. Comprehensive Reverse $250 1 payment
  6. Trabecular Metal (TM) Shoulder $250 1 payment
  7. Hips-None $250 1 payment
  8. Comprehensive Shoulder $250 1 payment
  9. Comprehensive Shoulder System $162 2 payments
  10. Bioinductive Implant with Arthroscopic Delivery System - Medium $63 1 payment
  11. Other $182 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$66,282

Of which drugs: $212

Medicare patients

169

Average age 72

Services billed

661

85 women, 84 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Depression 26%
Diabetes 21%
Ischemic heart disease 21%
Cancer 19%
Chronic kidney disease 16%
Heart failure 14%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 55 288 $212

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Oregon

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record